Cancers
Early and Multimodal Care for Patients with Lung Cancer: Findings from the ACCEPT Study
By Christian Grah, Shiao Li Oei, Félix Kindler and 7 others.
Abstract
Objective
Treating lung cancer with a combination of targeted cancer therapy, supportive, and psychosocial treatments is important in modern oncology. The ACCEPT study investigated the efficacy of a 12-week early multimodal supportive care program on quality of life.
Methods
ACCEPT was a single-center, non-randomized, prospective, open-label trial, with a pragmatic real-world design guided by patient choice. Patients with newly diagnosed, stage II-IV lung cancer participated in the outpatient ACCEPT program (psycho-oncology, health education, and training-based interventions alongside standard care). Longitudinal patient-reported outcome measures (PROMs) were collected. The primary outcome was the change in quality of life at 12 weeks measured by the Trial Outcome Index (TOI). Secondary outcomes included further exploratory PROM changes and overall survival.